Pelthos Therapeutics (PTHS) announced John Gay has been appointed CFO, effective April 10. Gay succeeds Francis Knuettel II, who served as Pelthos’ CFO since July 2025. Gay has served as Senior Vice President, Finance & Accounting at Pelthos since 2025. He has more than 25 years of public company finance and accounting experience.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTHS:
- Pelthos Therapeutics initiated with an Overweight at Cantor Fitzgerald
- Pelthos Therapeutics doses first patient in CT2000 trial
- Pelthos Therapeutics Inc trading resumes
- Pelthos Therapeutics Inc trading halted, volatility trading pause
- Pelthos Therapeutics price target raised to $62 from $60 at Oppenheimer